Literature DB >> 11239467

Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2.

A Farooq1, G Chaturvedi, S Mujtaba, O Plotnikova, L Zeng, C Dhalluin, R Ashton, M M Zhou.   

Abstract

MAP kinases (MAPKs), which control mitogenic signal transduction in all eukaryotic organisms, are inactivated by dual specificity MAPK phosphatases (MKPs). MKP-3, a prototypical MKP, achieves substrate specificity through its N-terminal domain binding to the MAPK ERK2, resulting in the activation of its C-terminal phosphatase domain. The solution structure and biochemical analysis of the ERK2 binding (EB) domain of MKP-3 show that regions that are essential for ERK2 binding partly overlap with its sites that interact with the C-terminal catalytic domain, and that these interactions are functionally coupled to the active site residues of MKP-3. Our findings suggest a novel mechanism by which the EB domain binding to ERK2 is transduced to cause a conformational change of the C-terminal catalytic domain, resulting in the enzymatic activation of MKP-3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239467     DOI: 10.1016/s1097-2765(01)00186-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  46 in total

1.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

2.  Solution structure of the rhodanese homology domain At4g01050(175-295) from Arabidopsis thaliana.

Authors:  David Pantoja-Uceda; Blanca López-Méndez; Seizo Koshiba; Makoto Inoue; Takanori Kigawa; Takaho Terada; Mikako Shirouzu; Akiko Tanaka; Motoaki Seki; Kazuo Shinozaki; Shigeyuki Yokoyama; Peter Güntert
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

3.  Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5.

Authors:  Xiao Tao; Liang Tong
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

4.  Structural basis for the regulation of the mitogen-activated protein (MAP) kinase p38α by the dual specificity phosphatase 16 MAP kinase binding domain in solution.

Authors:  Ganesan Senthil Kumar; Heiko Zettl; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

Review 5.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

Review 6.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

7.  Assembly of the Sos1-Grb2-Gab1 ternary signaling complex is under allosteric control.

Authors:  Caleb B McDonald; Kenneth L Seldeen; Brian J Deegan; Vikas Bhat; Amjad Farooq
Journal:  Arch Biochem Biophys       Date:  2009-12-22       Impact factor: 4.013

8.  Dusp6 is a genetic modifier of growth through enhanced ERK activity.

Authors:  Andy H Vo; Kayleigh A Swaggart; Anna Woo; Quan Q Gao; Alexis R Demonbreun; Katherine S Fallon; Mattia Quattrocelli; Michele Hadhazy; Patrick G T Page; Zugen Chen; Ascia Eskin; Kevin Squire; Stanley F Nelson; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

9.  n-->pi* interactions in proteins.

Authors:  Gail J Bartlett; Amit Choudhary; Ronald T Raines; Derek N Woolfson
Journal:  Nat Chem Biol       Date:  2010-07-11       Impact factor: 15.040

Review 10.  Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening.

Authors:  Ahmet Bakan; John S Lazo; Peter Wipf; Kay M Brummond; Ivet Bahar
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.